COMPARISON OF IN VIVO ECCENTRICITY AND SYMMETRY INDICES BETWEEN METALLIC STENTS AND BIORESORBABLE VASCULAR SCAFFOLDS: INSIGHTS FROM THE ABSORB AND SPIRIT TRIALS

Salvatore Brugaletta; Josep Gómez‐Lara; Roberto Diletti; Vasim Farooq; Maria Radu; Robert‐Jan van Geuns; Bernard De Bruyne; Dariuz Dudek; Leif Thuesen; Bernard Chevalier; Dougal McClean; Stephan Windecker; Robert Whitbourn; Cécile Dorange; Dong Li; Susan Veldhof; Yoshinobu Onuma; Nico Bruining; Héctor M. García‐García; John A. Ormiston; Patrick W. Serruys

doi:10.1016/s0735-1097(11)61700-2

Shared by

Patrick W. Serruys

Imperial College London

COMPARISON OF IN VIVO ECCENTRICITY AND SYMMETRY INDICES BETWEEN METALLIC STENTS AND BIORESORBABLE VASCULAR SCAFFOLDS: INSIGHTS FROM THE ABSORB AND SPIRIT TRIALS

Journal of the American College of Cardiology 57(14): E1700-E1700

Article 2011 English

Authors

SB
Salvatore Brugaletta
JG
Josep Gómez‐Lara
RD
Roberto Diletti

Abstract

1 min read

No abstract is provided for this article.

Related publications

Article2011

Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials

Salvatore Brugaletta, Josep Gómez‐Lara, Roberto Diletti, Vasim Farooq, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys

Catheterization and Cardiovascular Interventions

Article2015

TCT-15 Multislice computed tomography assessment of absorb bioresorbable vascular scaffold in comparison with metallic drug-eluting stents: data from the ABSORB Japan trial

Kengo Tanabe, Ken Kozuma, Jeffrey J. Popma, Patrick W. Serruys, Takeshi Kimura

Journal of the American College of Cardiology

Article2015

ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL

Bernard Chevalier, Yuki Ishibashi, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2016

COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Maciej Banach, Maria Corina Serban, Amirhossein Sahebkar, Héctor M. García‐García, Dimitri P. Mikhailidis, Seth S. Martin, Brie Daniel, Jacek Rysz, Péter Tóth, Steven Jones, Rani K. Hasan, Svetlana Moşteoru, Mahmoud Al Rifai, Michael Pencina, Patrick W. Serruys

Journal of the American College of Cardiology

Article2020

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Yoshinobu Onuma, Bernard Chevalier, Masafumi Ono, Ángel Cequier, Dariusz Dudek, Michael Haude, Didier Carrié, Manel Sabaté, Stephan Windecker, Richard Rapoza, Nick E.J. West, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andrés Íñiguez, Patrick W. Serruys

EuroIntervention

COMPARISON OF IN VIVO ECCENTRICITY AND SYMMETRY INDICES BETWEEN METALLIC STENTS AND BIORESORBABLE VASCULAR SCAFFOLDS: INSIGHTS FROM THE ABSORB AND SPIRIT TRIALS

Abstract

Discussion(0)

Related publications

Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials

TCT-15 Multislice computed tomography assessment of absorb bioresorbable vascular scaffold in comparison with metallic drug-eluting stents: data from the ABSORB Japan trial

ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL

COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial